Skip to main content

AKBA

Akebia Therapeutics, Inc.

Company with tickers: AKBA

CIK
1517022
CUSIP
00972D105
Shares Outstanding
268,258,243
13F Activity (30d)
3 filings 2 filers

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-02-02 Butler John P. 341,305
2026-02-02 Rucci Carolyn M. 69,772
2026-02-02 Grund Nicholas 84,829
2026-02-02 Burke Steven Keith 67,658
2026-02-02 Ostrowski Erik 34,951
2025-06-30 Ostrowski Erik 41,314
2025-03-03 Burke Steven Keith 7,144
2025-03-03 Butler John P. 46,409
2025-02-03 Butler John P. 144,250
2025-02-03 Grund Nicholas 55,621
2025-02-03 Burke Steven Keith 50,506
2024-05-13 Hadas Nicole R. 12,016
2024-05-13 Dahan Michel 34,840
2024-02-29 Dahan Michel 8,661
2024-02-29 Hadas Nicole R. 5,974
2024-02-29 Butler John P. 46,570
2024-02-29 Burke Steven Keith 7,169
2024-02-27 Hadas Nicole R. 7,411
2024-02-27 Butler John P. 37,733
2024-02-27 Burke Steven Keith 8,367
2024-02-27 Dahan Michel 10,744
2024-02-01 Butler John P. 46,489
2024-02-01 Burke Steven Keith 24,311
2023-05-25 Hadas Nicole R. 63,186
2023-05-25 Dahan Michel 95,478
2023-05-16 Burke Steven Keith 63,567
2023-05-16 Spellman David A 63,567
Showing 1–27 of 27 filings